Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 104 results found. Search for [ Zydus Pharma ]

Results 1 to 21 of 104
PB Jayakumar
New Delhi, June 10, 2019
In spite of an expanding healthcare market, prevention and wellness do not get the attention they deserve


BusinessToday.In
New Delhi, May 29, 2019
Cadila Q4 consolidated net profit declines 22.1% year-on-year to Rs 460 crore, while revenue climbed 15.3 per cent to Rs 3,771.2 crore compared to the same quarter last year


BusinessToday.In
May 29, 2019
Except IT sector, all the other indices ended in the red in today's trade. Biggest fall in today's trade was seen in PSU Bank, which was down 2.8%, followed by Auto, Media, Infra, Energy and Metal, each declining over 1%. Only gaining sector of the day was IT, up 0.66%.


PTI
May 28, 2019
The Zydus Group firm had posted a net profit of Rs 36.25 crore for the corresponding period of the previous financial year


E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


Aprajita Sharma
May 14, 2019
The ongoing trade war between the US and China had triggered the recent correction in the market


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


PTI
March 29, 2019



E Kumar Sharma
New Delhi, March 27, 2019
This story is a part of BusinessToday.In series on unemployment titled 'Jobs - Reality Check'. Absence of reliable data has made unemployment a highly debated topic this election season. The series will try and answer some of the most prevalent questions related to the jobs scene in the country.


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Team BT
New Delhi, April 16, 2018
\"A leader should inspire people to dream and create the right environment for them to grow and evolve\"


PTI
March 15, 2018



PB Jayakumar
New Delhi, January 16, 2018
Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.


E. kumar sharma
New Delhi, December 11, 2017
Indian pharma companies are facing strong headwinds, but they are also exploring every new opportunity to ensure a quick recovery.


BusinessToday.in
December 8, 2017
Market breadth is positive with 1,860 stocks rising against 818 stocks falling on the BSE. Jet Airways stock trading 2.91 percent or 20 points lower at 676.50 level after Q2 net profit tanks 91%, top loser on BSE.


PB Jayakumar
New Delhi, December 5, 2017
The OTC business of Piramal, already among the top five OTC specialists in the Rs 20,000 crore market, had revenues of Rs 375 crore in 2016-17, a jump of 44 per cent compared to the Rs 261 crore it posted in the previous year.


PAGES 1 OF 6  12345